LONDON, Nov. 16, 2017 /PRNewswire/ -- Fore Pharma announced the results of its Asthma patients study in a new report 'Global Asthma Epidemiology and Patient Flow Analysis - 2017'.
Download the full report: https://www.reportbuyer.com/product/3895232The report provides insights into Asthma epidemiology, Asthma diagnosed patients, and Asthma treatment rate for top seven pharmaceutical markets. The study measures key indicators
such as prevalence of Asthma derived from epidemiological analysis, percentage of patients diagnosed with Asthma, and percentage of patients treated with a therapy. The study helps executives estimate Asthma market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Asthma prevalence, Asthma diagnosis rate, and Asthma treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources. Key Features of the Report:
- Asthma Patient Flow - Asthma Prevalence - Asthma Diagnosed Patients - Asthma Treated PatientsDownload the full report: https://www.reportbuyer.com/product/3895232
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: email@example.com
Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/global-asthma-epidemiology-and-patient-flow-analysis---2017-300558179.html